Tumor Necrosis Factor‐Alpha, Interleukin‐6, and Interleukin‐10 Levels are Altered in Preeclampsia: A Systematic Review and Meta‐Analysis

Published reports testing the association between cytokine levels and preeclampsia are conflicting. This comprehensive systematic review and meta‐analysis aimed at testing the association between preeclampsia and maternal circulating tumor necrosis factor‐alpha (TNF‐α), interleukin (IL)‐6, and IL‐10.

[1]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[2]  D. Charnock-Jones,et al.  Redefining preeclampsia using placenta-derived biomarkers. , 2013, Hypertension.

[3]  K. Wallace,et al.  Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia. , 2012, Gender medicine.

[4]  B. Tarlatzis,et al.  Elevated Serum Levels of Interleukin‐6, Interleukin‐1β and Human Chorionic Gonadotropin in Pre‐eclampsia , 2011, American journal of reproductive immunology.

[5]  Jiang-Bo Liu,et al.  A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. , 2011, Cytokine.

[6]  G. Wallukat,et al.  Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation. , 2011, International journal of interferon, cytokine and mediator research.

[7]  A. Szarka,et al.  Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[8]  A. Szarka,et al.  Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia , 2011, Reproductive biology and endocrinology : RB&E.

[9]  S. Hahn,et al.  Placental Microparticles, DNA, and RNA in Preeclampsia , 2011, Hypertension in pregnancy.

[10]  G. Wallukat,et al.  Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. , 2011, American journal of hypertension.

[11]  J. Gjedsted,et al.  Longitudinal measurement of cytokines in pre‐eclamptic and normotensive pregnancies , 2011, Acta obstetricia et gynecologica Scandinavica.

[12]  G. Wallukat,et al.  Angiotensin II Type 1 Receptor Antibodies and Increased Angiotensin II Sensitivity in Pregnant Rats , 2011, Hypertension.

[13]  R. Dechend,et al.  Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. , 2011, Gender medicine.

[14]  S. Blackwell,et al.  Autoantibody-Mediated IL-6–Dependent Endothelin-1 Elevation Underlies Pathogenesis in a Mouse Model of Preeclampsia , 2011, The Journal of Immunology.

[15]  J. Granger,et al.  Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. , 2011, Current opinion in pharmacology.

[16]  Archana Singh,et al.  Role of Endothelin and Inflammatory Cytokines in Pre‐eclampsia – A Pilot North Indian Study , 2011, American journal of reproductive immunology.

[17]  J. Granger,et al.  Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. , 2011, American journal of hypertension.

[18]  A. Szarka,et al.  Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array , 2010, BMC Immunology.

[19]  K. Lim,et al.  Growth Factors , Cytokines , Cell Cycle Molecules Sera from Preeclampsia Patients Elicit Symptoms of Human Disease in Mice and Provide a Basis for an in Vitro Predictive Assay , 2010 .

[20]  Maren S Fragala,et al.  Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research , 2010, Current opinion in clinical nutrition and metabolic care.

[21]  M. Tosun,et al.  Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[22]  Ioannis P Androulakis,et al.  Modeling the influence of circadian rhythms on the acute inflammatory response. , 2010, Journal of theoretical biology.

[23]  Qi Chen,et al.  The role of autocrine TGFβ1 in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre‐eclampsia , 2010, The Journal of pathology.

[24]  Judith E. Cartwright,et al.  Pre‐eclampsia: fitting together the placental, immune and cardiovascular pieces , 2010, The Journal of pathology.

[25]  P. Julien,et al.  Plasma interleukin‐18 (IL‐18) levels are correlated with antioxidant vitamin coenzyme Q10 in preeclampsia , 2010, Acta obstetricia et gynecologica Scandinavica.

[26]  M. Lindheimer,et al.  Interpreting Abnormal Proteinuria in Pregnancy: The Need for a More Pathophysiological Approach , 2010, Obstetrics and gynecology.

[27]  J. Granger,et al.  Role of Endothelin in Mediating Soluble fms-Like Tyrosine Kinase 1–Induced Hypertension in Pregnant Rats , 2010, HYPERTENSION.

[28]  P. von Dadelszen,et al.  Toll‐like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre‐eclampsia , 2010, BJOG : an international journal of obstetrics and gynaecology.

[29]  Archana Singh,et al.  ORIGINAL ARTICLE: Role of Inflammatory Cytokines and eNOS Gene Polymorphism in Pathophysiology of Pre‐Eclampsia , 2009, American journal of reproductive immunology.

[30]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[31]  P. Stone,et al.  IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. , 2010, Placenta.

[32]  J. Després,et al.  Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. , 2009, Metabolism: clinical and experimental.

[33]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[34]  H. Ayatollahi,et al.  Comparison of maternal serum Tumor Necrosis Factor-alpha (TNF-α) in severe and mild preeclampsia versus normal pregnancy , 2009 .

[35]  M. Jovanović,et al.  Interleukin-6 stimulates cell migration, invasion and integrin expression in HTR-8/SVneo cell line. , 2009, Placenta.

[36]  C. Hubel,et al.  The two stage model of preeclampsia: variations on the theme. , 2009, Placenta.

[37]  P. Stone,et al.  Vitamin C enhances phagocytosis of necrotic trophoblasts by endothelial cells and protects the phagocytosing endothelial cells from activation. , 2009, Placenta.

[38]  M. Aral,et al.  Association of Maternal Serum CRP, IL-6, TNF-α, Homocysteine, Folic Acid and Vitamin B12 Levels with the Severity of Preeclampsia and Fetal Birth Weight , 2009, Hypertension in pregnancy.

[39]  Yan-Qiong Ouyang,et al.  Interactions Between Inflammatory and Oxidative Stress in Preeclampsia , 2009, Hypertension in pregnancy.

[40]  P. Chedraui,et al.  Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[41]  P. Stone,et al.  A role for interleukin‐6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre‐eclampsia , 2009, The Journal of pathology.

[42]  I. Adam,et al.  Cytokines Profiles in Sudanese Women with Preeclampsia , 2009, Hypertension in pregnancy.

[43]  T. Noyan.  Serum Mast Cell Tryptase, Eosinophil Cationic Protein, Endothelin-1 and Cytokine Levels in Preeclampsia and Healthy Pregnancy (Preeklampsi ve Sağlikli Gebelikte Serum Mast Hücre Triptaz, Eozinofilik Katyonik Protein, Endotelin-1 ve Sitokin Seviyeleri ) Research Article (Araştirma Makalesi) , 2009 .

[44]  M. Emanuelli,et al.  Placental Cytokines in the Pathogenesis of Preeclampsia and Hellp Syndrome , 2008 .

[45]  E. Norwitz,et al.  Fractional Excretion of Tumor Necrosis Factor-&agr; in Women With Severe Preeclampsia , 2008, Obstetrics and gynecology.

[46]  Asif Ahmed,et al.  Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling , 2008, Hypertension.

[47]  B. Huppertz.  Placental Origins of Preeclampsia: Challenging the Current Hypothesis , 2008, Hypertension.

[48]  I. Sargent,et al.  Circulating microparticles in normal pregnancy and pre-eclampsia. , 2008, Placenta.

[49]  S. Founds,et al.  A Comparison of Circulating TNF-α in Obese and Lean Women with and without Preeclampsia , 2008, Hypertension in pregnancy.

[50]  M. Vaid,et al.  Inducible nitric oxide synthase (iNOS) gene polymorphism in pre‐eclampsia: A pilot study in North India , 2007, The Australian & New Zealand journal of obstetrics & gynaecology.

[51]  M. Vodjgani,et al.  Serum cytokines profiles in Iranian patients with preeclampsia. , 2007, Iranian journal of immunology : IJI.

[52]  Cenk Fatih Çanakçı,et al.  Periodontal disease increases the risk of severe pre-eclampsia among pregnant women. , 2007, Journal of clinical periodontology.

[53]  I. Sargent,et al.  Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles , 2007, The Journal of Immunology.

[54]  Alpana Sharma,et al.  Leptin, IL‐10 and Inflammatory Markers (TNF‐α, IL‐6 and IL‐8) in Pre‐Eclamptic, Normotensive Pregnant and Healthy Non‐Pregnant Women , 2007, American journal of reproductive immunology.

[55]  P. McKenzie,et al.  Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. , 2007, Kidney international.

[56]  G. Saade,et al.  The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. , 2007, American journal of obstetrics and gynecology.

[57]  Asif Ahmed,et al.  Angiotensin II Induces Soluble fms-Like Tyrosine Kinase-1 Release via Calcineurin Signaling Pathway in Pregnancy , 2007, Circulation research.

[58]  J. Després,et al.  Postprandial Variations of Plasma Inflammatory Markers in Abdominally Obese Men , 2006, Obesity.

[59]  B. Çetinarslan,et al.  Association between Circulating Tumor Necrosis Factor-Alpha, Interleukin-6, and Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome. , 2006, Metabolic syndrome and related disorders.

[60]  J. Ernerudh,et al.  Cytokine mapping of sera from women with preeclampsia and normal pregnancies. , 2006, Journal of reproductive immunology.

[61]  M. Lalu,et al.  Preeclampsia: current understanding of the molecular basis of vascular dysfunction , 2006, Expert Reviews in Molecular Medicine.

[62]  P. Stone,et al.  Phagocytosis of Necrotic but Not Apoptotic Trophoblasts Induces Endothelial Cell Activation , 2006, Hypertension.

[63]  E. Bursal,et al.  The Serum Interleukin-6 and Tumor Necrosis Factor-α Levels and Their Relationship With Antithrombin-III and von Willebrand Factor In Preeclampsia , 2006 .

[64]  L. Magee,et al.  Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. , 2006, Placenta.

[65]  James M. Roberts,et al.  Preeclampsia: recent insights. , 2005, Hypertension.

[66]  J. T. Afshari,et al.  Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia , 2005, BMC pregnancy and childbirth.

[67]  U. Singhal,et al.  Serum tumor necrosis factor-alpha in pre eclampsia. , 2005, Indian journal of physiology and pharmacology.

[68]  L. Khaodhiar,et al.  Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[69]  S. Karumanchi,et al.  Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. , 2004, Endocrinology.

[70]  S. Kōzuma,et al.  Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. , 2004, Endocrinology.

[71]  L. Cherry,et al.  Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia , 2004, Hypertension.

[72]  R. Khalil,et al.  Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[73]  A. Tuzcu,et al.  Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[74]  A. Omu,et al.  Connection between human leucocyte antigens D region and T helper cytokines in preeclampsia , 2004, Archives of Gynecology and Obstetrics.

[75]  S. Aydin,et al.  Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels , 2003, Acta obstetricia et gynecologica Scandinavica.

[76]  P. Steer,et al.  Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia. , 2003, Cardiovascular research.

[77]  K. Yoneyama,et al.  Increased Plasma Adenosine Concentrations and the Severity of Preeclampsia , 2002, Obstetrics and gynecology.

[78]  A. Duits,et al.  High Serum Interleukin‐8 Levels in Afro‐Caribbean Women with Pre‐eclampsia. Relations with Tumor Necrosis Factor‐α, Duffy Negative Phenotype and Von Willebrand Factor , 2002, American journal of reproductive immunology.

[79]  S. Djurovic,et al.  Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre‐eclampsia , 2002, BJOG : an international journal of obstetrics and gynaecology.

[80]  D. Charnock-Jones,et al.  Hypoxia-Reoxygenation: A Potent Inducer of Apoptotic Changes in the Human Placenta and Possible Etiological Factor in Preeclampsia , 2002, Circulation research.

[81]  B. Özçelik,et al.  Predictive value of tumor necrosis factor alpha (TNF-α) in preeclampsia , 2002 .

[82]  M. Başbuğ,et al.  Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[83]  P. López-Jaramillo,et al.  Elevated C‐reactive protein and pro‐inflammatory cytokines in Andean women with pre‐eclampsia , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[84]  J. Bartha,et al.  The relationships between leptin and inflammatory cytokines in women with pre‐eclampsia , 2001, BJOG : an international journal of obstetrics and gynaecology.

[85]  G. Burton,et al.  In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. , 2001, The American journal of pathology.

[86]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[87]  S. Humphries,et al.  Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. , 2000, Cytokine.

[88]  S. Olusi,et al.  Interleukins in preeclampsia. , 2000, Annals of Saudi medicine.

[89]  C. Mittermayer,et al.  Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[90]  P. Loizzi,et al.  Evaluation of Nonspecific Immunity and Plasma Levels of Interferon-γ, Interleukin-6 and Tumor Necrosis Factor-α in Preeclampsia , 1999 .

[91]  A. Omu,et al.  Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. , 1999, Acta obstetricia et gynecologica Scandinavica.

[92]  L C Harrison,et al.  Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. , 1998, Cytokine.

[93]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[94]  R. Grimble,et al.  Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids. , 1998, Zeitschrift fur Ernahrungswissenschaft.

[95]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[96]  C. Mantzoros,et al.  Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans , 1997 .

[97]  S. Kōzuma,et al.  Evidence for an Elevation in Serum Interleukin‐2 and Tumor Necrosis Factor‐α Levels Before the Clinical Manifestations of Preeclampsia , 1997, American journal of reproductive immunology.

[98]  A. Peaceman,et al.  Soluble tumor necrosis factor receptors and interleukin‐6 levels in patients with severe preeclampsia , 1996, Obstetrics and gynecology.

[99]  S. Bulun,et al.  Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells , 1996, Molecular and Cellular Endocrinology.

[100]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[101]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[102]  D. Kwiatkowski,et al.  Interleukin‐6, turnour necrosis factor and soluble turnour necrosis factor receptors in women with pre‐eclampsia , 1995 .

[103]  D. Kwiatkowski,et al.  Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. , 1995, British journal of obstetrics and gynaecology.

[104]  I. Greer,et al.  Increased concentrations of dytokines interleukin and interleukin‐1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? , 1994, Obstetrics and gynecology.

[105]  Jean Golding,et al.  Geographic variation in incidence of hypertension in pregnancy , 1988 .

[106]  J. Meer,et al.  Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. , 1988, Lymphokine research.

[107]  R. Cotran,et al.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.